Literature DB >> 18049893

Antioxidant enzyme activities following acute or chronic methylphenidate treatment in young rats.

Karin M Gomes1, Fabrícia C Petronilho, Mariane Mantovani, Thereza Garbelotto, Carina R Boeck, Felipe Dal-Pizzol, João Quevedo.   

Abstract

Methylphenidate (MPH) is psychostimulants used to treat Attention-Deficit/Hyperactivity Disorder and can lead to a long-lasting neurochemical and behavioral adaptations in experimental animals. In the present study, the cerebral antioxidant enzymatic system, superoxide dismutase (SOD) and catalase (CAT) was evaluated at in different age following MPH (1, 2 or 10 mg/kg MPH, i.p.) treatment in young rats. In the acute treatment the SOD activity decreased in the cerebral prefrontal cortex with opposite effect in the cerebral cortex; and the CAT activity decreased in hippocampus. In the chronic treatment the SOD activity increased in the hippocampus and cerebral cortex and decreased in the striatum. The observed changes on the enzyme activities in rat brain were dependent on the structure brain region and duration of treatment with MPH. Probably, the activity of enzymes was not be enough to prevent MPH-induced oxidative damage in specific regions from brain, such as observed for us in another recent study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18049893     DOI: 10.1007/s11064-007-9544-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  22 in total

1.  Psychotropic drug use in very young children.

Authors:  J T Coyle
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 2.  D(1) receptors in prefrontal cells and circuits.

Authors:  P S Goldman-Rakic; E C Muly; G V Williams
Journal:  Brain Res Brain Res Rev       Date:  2000-03

Review 3.  Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Authors:  Amy F T Arnsten; Bao-Ming Li
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

Review 4.  Attention-deficit hyperactivity disorder and hyperkinetic disorder.

Authors:  J M Swanson; J A Sergeant; E Taylor; E J Sonuga-Barke; P S Jensen; D P Cantwell
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

5.  Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats.

Authors:  Ana O Fagundes; Gislaine T Rezin; Francine Zanette; Eliane Grandi; Lara C Assis; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Int J Dev Neurosci       Date:  2006-12-22       Impact factor: 2.457

6.  Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop.

Authors:  G Bush; J A Frazier; S L Rauch; L J Seidman; P J Whalen; M A Jenike; B R Rosen; J Biederman
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

Review 7.  Antioxidants, oxidative stress, and degenerative neurological disorders.

Authors:  R A Floyd
Journal:  Proc Soc Exp Biol Med       Date:  1999-12

8.  Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.

Authors:  Verónica Sandoval; Evan L Riddle; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurosci       Date:  2002-10-01       Impact factor: 6.167

9.  Widespread origin of the primate mesofrontal dopamine system.

Authors:  S M Williams; P S Goldman-Rakic
Journal:  Cereb Cortex       Date:  1998-06       Impact factor: 5.357

10.  Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.

Authors:  Dawn D Han; Howard H Gu
Journal:  BMC Pharmacol       Date:  2006-03-03
View more
  10 in total

1.  Chronic oral methylphenidate treatment increases microglial activation in rats.

Authors:  Emily Carias; John Hamilton; Lisa S Robison; Foteini Delis; Rina Eiden; Teresa Quattrin; Michael Hadjiargyrou; David Komatsu; Panayotis K Thanos
Journal:  J Neural Transm (Vienna)       Date:  2018-09-20       Impact factor: 3.575

2.  Diurnal differences in memory and learning in young and adult rats treated with methylphenidate.

Authors:  Karin M Gomes; Clarissa M Comim; Samira S Valvassori; Gislaine Z Réus; Cecília G Inácio; Márcio R Martins; Renan P Souza; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-03-06       Impact factor: 3.575

3.  Methylphenidate Decreases ATP Levels and Impairs Glutamate Uptake and Na+,K+-ATPase Activity in Juvenile Rat Hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

4.  Methylphenidate induces lipid and protein damage in prefrontal cortex, but not in cerebellum, striatum and hippocampus of juvenile rats.

Authors:  Felipe Schmitz; Emilene B S Scherer; Fernanda R Machado; Aline A da Cunha; Bárbara Tagliari; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2012-09-12       Impact factor: 3.584

5.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

6.  Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cells.

Authors:  Vanessa Coelho-Santos; Renato Socodato; Camila Portugal; Ricardo A Leitão; Manuel Rito; Marcos Barbosa; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Richard D Minshall; Carlos Fontes-Ribeiro; Teresa Summavielle; João B Relvas; Ana P Silva
Journal:  Cell Mol Life Sci       Date:  2016-07-04       Impact factor: 9.261

7.  Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.

Authors:  Shankar Sadasivan; Brooks B Pond; Amar K Pani; Chunxu Qu; Yun Jiao; Richard J Smeyne
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

8.  Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats.

Authors:  Felipe Ornell; Samira S Valvassori; Amanda V Steckert; Pedro F Deroza; Wilson R Resende; Roger B Varela; João Quevedo
Journal:  Behav Neurol       Date:  2014-11-06       Impact factor: 3.342

9.  Decreased Serum Cu/Zn SOD Associated with High Copper in Children with Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  A J Russo
Journal:  J Cent Nerv Syst Dis       Date:  2010-05-04

Review 10.  Antioxidants as a Potential Target against Inflammation and Oxidative Stress in Attention-Deficit/Hyperactivity Disorder.

Authors:  Lourdes Alvarez-Arellano; Nadia González-García; Marcela Salazar-García; Juan Carlos Corona
Journal:  Antioxidants (Basel)       Date:  2020-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.